Study Comparing OsseoSpeed™ Implants of Two Different Lengths in the Upper and Lower Posterior Jaw



Status:Completed
Conditions:Dental
Therapuetic Areas:Dental / Maxillofacial Surgery
Healthy:No
Age Range:20 - 70
Updated:8/9/2018
Start Date:November 2007
End Date:May 2016

Use our guide to learn which trials are right for you!

An Open, Prospective, Randomized, Multi-center Study Comparing OsseoSpeed™ Implant 6 mm With OsseoSpeed™ Implant 11 mm in the Posterior Maxilla and Mandible. A 5-year Follow-up Study.

The purpose of this study is to see if OsseoSpeed™ implant 6 mm long is effective for
rehabilitation of edentulism and if so, how it compares with OsseoSpeed™ implant 11 mm long.
The primary hypothesis is that the alteration in bone level is equal in patients randomized
to 6 mm as to patients randomized to 11 mm implants.


Inclusion Criteria:

- Provision of informed consent

- Aged 20-70 years at enrolment

- History of edentulism in the study area of at least four months

- Neighboring tooth/teeth to the planned bridge must have natural root(s)

- Presence of natural teeth, partial prosthesis and/or implants in the opposite jaw in
contact with the planned bridge.

- Deemed by the investigator to have a bone height of at least 11 mm and a bone width of
minimum 6 mm

- Deemed by the investigator as likely to present an initially stable implant situation

Exclusion Criteria:

- Unlikely to be able to comply with study procedures, as judged by the investigator

- Earlier graft procedures in the study area

- Uncontrolled pathologic processes in the oral cavity

- Known or suspected current malignancy

- History of radiation therapy in the head and neck region

- History of chemotherapy within 5 years prior to surgery

- Systemic or local disease or condition that could compromise post-operative healing
and/or osseointegration

- Uncontrolled diabetes mellitus

- Corticosteroids or any other medication that could influence post-operative healing
and/or osseointegration

- Smoking more than 10 cigarettes/day

- Present alcohol and/or drug abuse

- Involvement in the planning and conduct of the study (applies to both Astra Tech staff
and staff at the study site)

- Previous enrolment in the present study.

- Severe non-compliance to protocol as judged by the investigator and/or Astra Tech

- Simultaneous participation in another clinical study, or participation in a clinical
study during the last 6 months
We found this trial at
3
sites
10518
mi
from 02139
Melbourne,
Click here to add this to my saved trials
1047
mi
from 02139
Iowa City, IA
Click here to add this to my saved trials
Los Angeles, California 90089
2591
mi
from 02139
Los Angeles, CA
Click here to add this to my saved trials